Summit Therapeutics Inc.SMMTNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
0.00%
↑ 100% vs avg
Percentile
P79
Within normal range
Average
-2572.94%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.00% | - |
| 2024 | 0.00% | - |
| 2023 | 0.00% | +100.0% |
| 2022 | -10381.73% | -118.6% |
| 2021 | -4748.76% | +19.4% |
| 2020 | -5889.77% | -69.7% |
| 2019 | -3470.01% | -16895.7% |
| 2018 | 20.66% | +111.2% |
| 2017 | -184.01% | +82.9% |
| 2016 | -1075.80% | - |